Marketing Protein Expression Research Laboratories 
Codon
DECEMBER 10, 2023
Large-scale experiments suggest that <50% of bacterial proteins and <15% of non-bacterial proteins express within E. This is the reason why many biologics — medicines made by, or extracted from, living cells — don’t make it to market. coli , yeast, and other types of organisms.
PPD
OCTOBER 12, 2023
These treatments use a vector to introduce the desired nucleic acid code to replace or modify protein expression or use cells to alter/restore a specific cell type. There are over 2,000 CGTs currently being evaluated in clinical trials, with more than 200 in Phase III and 10-20 per year estimated to come to market by 2025.
Codon
DECEMBER 10, 2023
Large-scale experiments suggest that <50% of bacterial proteins and <15% of non-bacterial proteins express within E. This is the reason why many biologics — medicines made by, or extracted from, living cells — don’t make it to market. coli , yeast, and other types of organisms.
Expert insights. Personalized for you.
87 
Let's personalize your content